CIK 0001087294 · Non-accelerated filer<br>Smaller reporting company
CUMBERLAND PHARMACEUTICALS INC
Sign in to watch- Ticker
- CPIX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- TN
- Entity type
- operating
- EIN
- 621765329
- Phone
- 615-255-0068
- Business address
- 1600 WEST END AVENUE, SUITE 1300, NASHVILLE,, TN, 37203
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 71 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-08-18 | Jones James Director | Other acquisition 10b5-1 | +65 | $1.70 | $111 | 27,488 |
| 2023-08-18 | Young Caroline Director | Other acquisition 10b5-1 | +65 | $1.70 | $111 | 20,782 |
| 2023-08-18 | KAZIMI A J Chairman and CEO | Other acquisition 10b5-1 | +65 | $1.70 | $111 | 5,716,348 |
| 2023-08-17 | Krogulski Kenneth Director | Other acquisition 10b5-1 | +325 | $1.73 | $562 | 210,605 |
| 2023-08-17 | Jones James Director | Other acquisition 10b5-1 | +65 | $1.70 | $111 | 27,423 |
| 2023-08-17 | Young Caroline Director | Other acquisition 10b5-1 | +65 | $1.70 | $111 | 20,717 |
| 2023-08-17 | KAZIMI A J Chairman and CEO | Other acquisition 10b5-1 | +65 | $1.70 | $111 | 5,716,283 |
| 2023-08-16 | Krogulski Kenneth Director | Other acquisition 10b5-1 | +325 | $1.67 | $543 | 210,280 |
| 2023-08-16 | Jones James Director | Other acquisition 10b5-1 | +65 | $1.64 | $107 | 27,358 |
| 2023-08-16 | Young Caroline Director | Other acquisition 10b5-1 | +65 | $1.64 | $107 | 20,652 |
| 2023-08-16 | KAZIMI A J Chairman and CEO | Other acquisition 10b5-1 | +65 | $1.64 | $107 | 5,716,218 |
| 2023-03-24 | Hamm John M. Chief Financial Officer | Grant or award · Options (right to buy) | +2,000 | 7,000 | ||
| 2023-03-24 | Anthony Todd M. Vice Pres Organizational Dev | Grant or award · Options (right to buy) | +3,000 | 12,000 | ||
| 2023-03-24 | Bitterman Chris T. Vice Pres Sales & Marketing | Grant or award · Options (right to buy) | +5,500 | 12,500 | ||
| 2023-03-24 | Herman James L VP and Chief Compliance Office | Grant or award · Options (right to buy) | +4,000 | 12,000 | ||
| 2023-03-24 | KAZIMI A J Chairman and CEO | Grant or award · Options (right to buy) | +100,000 | 268,000 | ||
| 2023-03-24 | Brown Martin S JR Director | Grant or award | +1,000 | $1.97 | $2K | 5,000 |
| 2023-03-24 | Galante Joseph C Director | Grant or award | +1,000 | $1.92 | $2K | 58,356 |
| 2023-03-24 | Young Caroline Director | Grant or award | +1,000 | $1.97 | $2K | 20,587 |
| 2023-03-24 | Jones James Director | Grant or award | +1,000 | $1.97 | $2K | 27,293 |
Page 90 of 207 · 4,129 trades